학술논문
Lanadelumab And Cardiovascular Risk: Findings From The Phase 3 HELP Study
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology February 2019 143(2) Supplement:AB45-AB45
Subject
Language
ISSN
0091-6749